Jennifer Miao
- Indexed articles, last 90 days
- 1
- Latest publication
- Sep 8, 2026
- Outlet visibility, for Abc7Chicago
- Top 50K sites
- Earliest in this view
- Sep 8, 2026
Latest articles
New drug shows promise in reducing COPD symptoms in former and current smokers, clinical trials show (opens the original)
Read excerpt
COPD is one of the top 10 leading cause of death in the U.S., the CDC says. A new drug appeared to show promise in reducing rates of chronic obstructive pulmonary disease (COPD) symptoms in former and current smokers, according to results from late-stage clinical trials. The medication, called tozorakimab and developed by AstraZeneca, is the first biologic drug to show efficacy in treating COPD symptoms in a broad population of patients with varying ranges of blood eosinophil counts, according t
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Abc7Chicago, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.